Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury

Summary

The primary objective of the study is to compare the efficacy of duloxetine 60 mg by mouth daily with placebo in the prevention of depression associated with mild/moderate traumatic brain injury and to enhance cognitive function.

Timeline

Start

1996-09

Primary completion

2011-07

Completion

2011-07

Drugs

Indications